2.9 C
New York
Tuesday, February 7, 2023

Subscribe

Moderna’s Personalized mRNA Cancer Vaccine Shows Promising Results in Early Trial

Moderna’s personalized cancer vaccine was shown to reduce the risk of recurrence in patients with stage 3 or 4 melanoma in a phase 2b clinical trial. …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

159,281FansLike
406,809FollowersFollow
2,160SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x